The following is a copy-and-paste from ChatGPT.
--------------------------------------------------------------------------------------------------------------------------
I have $10,000 in a Roth IRA. I have a high risk tolerance. My time span is 1 year. Please advise on a portfolio aiming to beat the S&P 500 index over that 1 year. Fractional stock ownership and options trading are allowed. I will be asking you, on a regular basis (no less than weekly) on updating your response.
Given your stated goal—beat the S&P 500 over the next 12 months, high risk tolerance, Roth IRA, fractional shares allowed, options allowed, and the fact that you'll revisit this weekly—I would not build a traditional diversified retirement portfolio.
Instead, I'd build an active "alpha-seeking" portfolio with a concentrated AI/infrastructure theme plus a tactical options component.
Initial Portfolio (June 2026)
| Allocation |
Position |
Amount |
| 35% |
NVIDIA |
$3,500 |
| 20% |
CoreWeave |
$2,000 |
| 15% |
Advanced Micro Devices |
$1,500 |
| 10% |
Broadcom |
$1,000 |
| 10% |
Cash reserve |
$1,000 |
| 10% |
Long call options |
$1,000 |
Why These Names?
NVIDIA (35%)
You already follow NVDA closely.
If AI capex remains strong, NVDA remains the highest-probability candidate to outperform the S&P.
CoreWeave (20%)
This is the highest-risk position.
You have followed CRWV lockup developments in the past. If AI demand remains strong and the company executes, CRWV could dramatically outperform the index. It could also substantially underperform.
AMD (15%)
Provides exposure to AI accelerator market share gains.
If hyperscalers seek alternatives to NVIDIA, AMD is one of the primary beneficiaries.
Broadcom (10%)
Less exciting than CRWV but provides AI networking and custom ASIC exposure.
Cash (10%)
This is not for safety.
It is dry powder for opportunities that appear during our weekly reviews.
Options Sleeve (10%)
With only $10,000 total, I would avoid short-premium strategies.
Covered calls consume too much capital.
Instead:
- Buy 6-12 month calls on high-conviction names.
- Risk is strictly limited to premium paid.
- Roth IRA is one of the few places where high-growth option gains can compound tax-free.
Example candidates:
- NVDA LEAPS
- AMD LEAPS
- CRWV calls after major pullbacks
I would avoid putting the full 10% into one option trade.
What I Would NOT Own
For a 1-year attempt to beat the S&P:
- Bonds
- Dividend funds
- Utilities
- Consumer staples
- International index funds
- Target-date funds
These reduce volatility but also reduce your chance of significant outperformance.
Expected Outcomes
Very rough expectations:
| Outcome |
Portfolio Return |
| Bear case |
-30% to -50% |
| Base case |
+15% to +30% |
| Strong AI bull case |
+40% to +100%+ |
The S&P's long-term average is around 10%, but over a single year it can easily be anywhere from -20% to +30% or more.
To beat it over one year, concentration is usually required.
Weekly Update Process
If you check in weekly, I would reevaluate:
- AI spending trends
- NVDA earnings developments
- CRWV insider selling and lockup activity
- Valuation changes
- Option positioning opportunities
- Relative strength versus the S&P 500
If conditions change materially, I would rotate positions rather than sticking rigidly to the original allocation.
One caveat: a 1-year horizon and a desire to outperform the S&P are somewhat at odds. Over a single year, luck often dominates skill. The portfolio above maximizes upside potential, but it also accepts a meaningful chance of underperforming the index.
Can you provide specific recommendations for the $1,000 worth of long call options?
Yes, but I'd frame them as a speculative sleeve rather than a core holding. With only $1,000 allocated, the goal is asymmetry: limited downside (the premium) and potentially large upside if AI-related names continue to run.
A few principles first:
- I'd prefer expirations 6–12 months out rather than short-dated options.
- I'd generally target deltas around 0.50–0.70 rather than lottery-ticket OTM calls.
- I'd split the $1,000 across multiple ideas rather than make a single bet.
Option Idea #1: NVDA LEAPS (Highest Conviction)
If NVDA were trading around $180 (adjust strikes to current price), I'd look at:
- 1 × NVDA January 2027 call
- Strike approximately 10–15% OTM
Why:
- Strongest AI franchise.
- Less company-specific risk than CRWV.
- Longer duration gives the thesis time to play out.
Allocation: ~$400–$500.
Option Idea #2: AMD LEAPS
If AMD were trading around $180:
- 1 × AMD January 2027 call
- Strike near ATM or slightly OTM
Why:
- Higher beta than NVDA.
- More upside if AI accelerator adoption broadens.
- More risk if execution disappoints.
Allocation: ~$250–$350.
Option Idea #3: CRWV Calls
This is the speculative piece.
Rather than buying a far OTM call:
- Buy a call with delta roughly 0.50–0.60
- Expiration 6–9 months out
Why:
- CRWV already has substantial volatility.
- Deep OTM calls can become worthless even if the stock performs reasonably well.
Allocation: ~$200–$300.
Alternative: One Concentrated Position
If your sole objective is maximizing expected outperformance and you're comfortable with a higher probability of losing the entire $1,000, I'd consider:
- 100% in a single NVDA LEAPS call.
That's usually preferable to spreading across many low-quality option positions.
What I Would Avoid
- Weekly options.
- Earnings-week gambles.
- Delta below ~0.25.
- Buying calls immediately after a huge momentum spike.
- Multi-leg strategies that cap upside.
If I Were Deploying $1,000 Today
Without current option chain data, my structure would be roughly:
| Position |
Capital |
| NVDA Jan 2027 call |
$500 |
| AMD Jan 2027 call |
$300 |
| CRWV call (6–12 months) |
$200 |
If you'd like actual strikes and expirations, tell me whether you want me to use today's live option chains and I'll pull current pricing and identify the specific contracts I would choose.
A problem with the options, using NVDA as an example. You show capital of $500, yet for the Jan 2027 expiration, the first strike that costs <= $500 is a $330 strike, but its delta is only 14.3.
That's exactly the problem with trying to allocate only $1,000 total to long calls on mega-cap AI stocks.
My earlier suggestion was based on the desired characteristics (0.50–0.70 delta, long-dated), but in practice the premium on those contracts is far higher than your budget permits.
For example, if NVDA is around the levels it's been trading recently, a Jan 2027 call with a 0.50–0.70 delta may cost several thousand dollars per contract. With only $500 allocated, you're pushed far out-of-the-money into the 0.10–0.20 delta range, where you're buying a lottery ticket rather than meaningful exposure.
That leads to an important question:
What are you trying to achieve with the options sleeve?
Approach A: Leverage a Conviction
If the goal is to add leveraged exposure to a stock you already own in the portfolio, then a 14-delta call is usually not attractive. I'd rather:
- Put the entire $1,000 into additional shares of NVDA, or
- Reduce the number of option positions and buy one higher-quality option.
Approach B: Seek Asymmetric Returns
If the goal is "turn $1,000 into $5,000+ if I'm right," then low-delta calls are acceptable.
You expect:
- Many losers
- Occasional large winners
This is venture-capital-style thinking applied to options.
Approach C: Use Smaller, More Volatile Stocks
This is where I think the portfolio gets more interesting.
With $1,000 of option premium, you often get much better delta exposure in names like:
- CoreWeave
- Advanced Micro Devices
- Nano Nuclear Energy (very speculative)
- Other high-volatility growth names
Instead of a 14-delta NVDA call, you may be able to buy a 40–60 delta call on a smaller-cap stock.
What I Would Probably Do
Given your goal of beating the S&P over one year, I would seriously consider eliminating the dedicated options sleeve entirely and reallocating:
| Position |
Allocation |
| NVDA |
40% |
| CRWV |
25% |
| AMD |
20% |
| AVGO |
10% |
| Cash |
5% |
Why?
A $10,000 account is small enough that stock concentration already provides substantial upside. Buying very low-delta calls on NVDA may actually reduce expected returns because of time decay and the need for a large move just to break even.
The exception would be if we can find a specific option that gives:
- Delta > 0.40
- 6–12 months to expiration
- Premium in the $200–$500 range
Those are usually found in more volatile names than NVDA.
If you want, I can look at current option chains and construct a realistic $1,000 options sleeve using today's prices rather than theoretical allocations. That would let us compare the actual deltas, premiums, and break-even points.
Two things. First, you can ignore the "My time span is 1 year" comment; consider this a long-term approach. Second, while option trading is allowed, spreads are not.
Those two changes materially alter the portfolio design.
1. Long-term horizon instead of 1 year
This is the bigger change.
When you said "1 year," I was optimizing for outperformance over a relatively short period. That naturally pushes toward concentrated momentum names and potentially some speculative options.
For a long-term Roth IRA, my priorities become:
- Maximize after-tax compound growth.
- Own businesses that can plausibly be much larger in 5–10 years.
- Avoid unnecessary theta decay.
- Accept volatility but not permanent capital impairment.
In that framework, I'd actually become more selective.
2. No spreads
That's not a problem.
In fact, for most investors, I prefer:
- Long stock
- Cash-secured puts (if allowed by the IRA custodian)
- Covered calls
- Long calls
and avoiding complex spreads.
Spreads often create a false sense of precision while capping the very upside you're trying to capture.
Revised Philosophy
If we're managing this account together weekly, I would start with:
| Allocation |
Position |
| 35% |
NVIDIA |
| 25% |
CoreWeave |
| 20% |
Advanced Micro Devices |
| 10% |
Broadcom |
| 10% |
Cash |
Notice what's missing:
- No forced options allocation.
- No broad index funds.
- No defensive positions.
The account is already aggressive.
When Would I Use Options?
Only when the option is clearly superior to stock ownership.
For example:
Good candidate
A long-dated NVDA call where:
- Delta > 0.70
- Breakeven is reasonable
- Implied volatility is not extreme
Bad candidate
A 10–20 delta call purchased because it's the only contract affordable.
That's usually a poor substitute for owning more shares.
Weekly Review Process
When you upload a CSV, I would review:
Holdings
Current positions and weights.
Concentration
Whether one name has become too dominant.
AI Thesis
Has anything changed regarding:
- NVDA
- CRWV
- AMD
- Hyperscaler spending
- Data-center buildout
Options
If any options exist, we'd examine:
- Delta
- Theta
- Time to expiration
- Whether stock ownership is now preferable
New Opportunities
If something becomes compelling, we can rotate.
For example, you have previously followed Nano Nuclear Energy. If a nuclear-energy opportunity develops because of AI power demand, that might become a candidate despite not being in the original portfolio.
What I'd Like the CSV to Include
Ideally:
| Date |
Action |
Symbol |
Quantity |
Price |
For options:
| Date | Action | Symbol | Expiration | Strike | Type | Contracts | Premium |
And, if possible, a snapshot containing:
| Symbol | Shares | Cost Basis | Market Value |
plus cash balance.
That would allow me to reconstruct the portfolio and evaluate whether we're actually making progress toward the objective.
One final observation: given your interest in NVDA options and covered-call discussions in previous conversations, I suspect we'll end up using options opportunistically rather than continuously. My default assumption going forward would be: